Apyx Medical Corporation Share Price

Equities

APYX

US03837C1062

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
1.45 USD -2.03% Intraday chart for Apyx Medical Corporation +9.85% -44.66%
Sales 2024 * 49.94M 4.16B Sales 2025 * 54.52M 4.55B Capitalization 50.23M 4.19B
Net income 2024 * -27M -2.25B Net income 2025 * -25M -2.08B EV / Sales 2024 * 1.01 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.92 x
P/E ratio 2024 *
-1.86 x
P/E ratio 2025 *
-2.08 x
Employees 252
Yield 2024 *
-
Yield 2025 *
-
Free-Float 82.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.03%
1 week+9.85%
Current month+6.62%
1 month+13.28%
3 months-36.12%
6 months-40.57%
Current year-44.66%
More quotes
1 week
1.21
Extreme 1.21
1.59
1 month
1.21
Extreme 1.21
1.64
Current year
1.21
Extreme 1.21
2.80
1 year
1.21
Extreme 1.21
7.97
3 years
1.21
Extreme 1.21
17.50
5 years
1.21
Extreme 1.21
17.50
10 years
1.21
Extreme 1.21
17.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 15/17/15
Founder 82 01/78/01
Director of Finance/CFO 56 04/12
Members of the board TitleAgeSince
Founder 82 01/78/01
Director/Board Member 77 15/11/15
Director/Board Member 63 09/18/09
More insiders
Date Price Change Volume
26/24/26 1.45 -2.03% 58,368
25/24/25 1.48 -1.33% 68,488
24/24/24 1.5 +13.64% 187,605
23/24/23 1.32 +4.76% 54,670
22/24/22 1.26 -4.55% 77,365

Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST

More quotes
Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and OEM. The Advanced Energy segment's product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It is focused on the cosmetic surgery market where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue to achieve their desired results. Its product lines consist of a multifunction generator, a handpiece and a supply of helium gas. The OEM segment leverages its expertise in the design, development and manufacturing of electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers through original equipment manufacturing agreements, as well as start-up companies with the need for its energy-based designs.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.45 USD
Average target price
3.625 USD
Spread / Average Target
+150.00%
Consensus